DPIIT recognised startup Government of India
Startup India
Nexline Pharma Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.04 Cr
▲ 21% YoY
Net loss · FY 2025
₹39,539
Net margin -0.4%
EBITDA · FY 2025
-₹25,946
EBITDA margin -0.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Nexline Pharma Private Limited
Data last updated:
Nexline Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24200RJ2020PTC067688. Its GSTIN is 08AAGCN8289B1Z6 (Rajasthan). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Verma and Pintu Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 37B Varun Colony Golyawas New Sanganer Road, Jaipur, Rajasthan, India – 302020.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.04 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹39,539 (net margin -0.4%) and EBITDA of -₹25,946 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years.
Nexline Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0017883). For more details, the company can be reached via its website nexlinepharma.com.
Company details
CIN U24200RJ2020PTC067688
Registration Number 067688
Incorporation Date 07 January 2020
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0017883
Recognitions & Rankings of Nexline Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0017883
Contact details
Nexline Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its website is nexlinepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 37B Varun Colony Golyawas New Sanganer Road, Jaipur, Rajasthan, India – 302020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nexline Pharma Private Limited, buy the company report.
Comprehensive company report
Nexline Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nexline Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nexline Pharma Private Limited, buy the company report.
Financials of Nexline Pharma Private Limited
FY 2025 filings availableNexline Pharma Private Limited reported revenue of ₹1.04 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹1.04 Cr ▲ 21%
Net loss · FY 2025
₹39,539 margin -0.4%
EBITDA · FY 2025
-₹25,946 margin -0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 80%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▼ 148%
Revenue has grown at a compounded annual rate (CAGR) of 80% over three years, including 21% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹25,946 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹39,539 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nexline Pharma Private Limited, buy the company report.
Board of directors of Nexline Pharma Private Limited
Nexline Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pintu Verma | Additional Director | 02 Sep 2020 | 6 Years 1 Months | Current |
| Manish Verma Also directs: Nexline Herbals Private Limited | Director | 07 Jan 2020 | 6 Years 9 Months | Current |
Peer comparison
Nexline Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alive Healthcare Private Limited | ₹1.04 Cr (FY 2025) | 215.0% | Rajkot, Gujarat, India | |||
| Mumo Industries and Services Private Limited | ₹1.04 Cr (FY 2024) | Hyderabad, Telangana, India | ||||
| Chemique Private Limited | ₹1.04 Cr (FY 2018) | -64.0% | New Delhi, Delhi, India | |||
| Nexline Pharma Private Limitedthis company | ₹1.04 Cr (FY 2025) | -₹39,539 | -0.4% | 21.0% | Jaipur, Rajasthan, India | |
| Thio Medicare Private Limited | ₹1.04 Cr (FY 2025) | 14.0% | Hyderabad, Telangana, India | |||
| Scan Biotech Limited | ₹1.04 Cr (FY 2024) | -65.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Nexline Pharma Private Limited, buy the company report.
Auditor
Nexline Pharma Private Limited is audited by AKSHAY KUMAR GUPTA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKSHAY KUMAR GUPTA | FY 2023 | 431640 |
Shareholding
The shareholding of Nexline Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nexline Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nexline Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexline Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nexline Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCN8289B1Z6 | Rajasthan | Active | 12 Nov 2021 |
| 18AAGCN8289B1Z5 | Assam | Active | 10 Feb 2020 |
To see the full GST registrations and return filing status of Nexline Pharma Private Limited, buy the company report.
Recent activity
Nexline Pharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Ram Avtar Chhaba ceased to be Director on 03 Sep 2020.
AGM
Nexline Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nexline Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Ceased
Ram Avtar Chhaba ceased to be Director.
Appointed
Pintu Verma was appointed as Additional Director.
Appointed
Manish Verma was appointed as Director.
Incorporation
07 Jan 2020
Nexline Pharma Private Limited was registered on 07 Jan 2020 with Roc Jaipur & aged 6 years 9 months as per MCA records.
Frequently asked questions
Nexline Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 January 2020 (6+ years old) and is registered under CIN U24200RJ2020PTC067688.
Nexline Pharma has 2 current directors:
- Pintu Verma - Additional Director
- Manish Verma - Director
The latest financial statements of Nexline Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Nexline Pharma is 08AAGCN8289B1Z6, registered in Rajasthan. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 18AAGCN8289B1Z5 (Assam).
The CIN (Corporate Identification Number) of Nexline Pharma is U24200RJ2020PTC067688. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexline Pharma was incorporated on 07 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Nexline Pharma by revenue are Alive Healthcare Private Limited, Mumo Industries and Services Private Limited, Chemique Private Limited, Thio Medicare Private Limited, Scan Biotech Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ram Avtar Chhaba ceased to be Director on 03 Sep 2020. Pintu Verma was appointed as Additional Director on 02 Sep 2020. Manish Verma was appointed as Director on 07 Jan 2020.
Yes, Nexline Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Nexline Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0017883).
Nexline Pharma can be reached through the website nexlinepharma.com. Its registered office is in Jaipur, Rajasthan, India.